SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-291732
Filing Date
2023-12-08
Accepted
2023-12-08 16:37:00
Documents
12
Period of Report
2023-12-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d648550d8k.htm   iXBRL 8-K 30960
  Complete submission text file 0001193125-23-291732.txt   154214

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ortx-20231206.xsd EX-101.SCH 2517
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20231206_lab.xml EX-101.LAB 17786
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20231206_pre.xml EX-101.PRE 11182
6 EXTRACTED XBRL INSTANCE DOCUMENT d648550d8k_htm.xml XML 3639
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 231475947
SIC: 2836 Biological Products, (No Diagnostic Substances)